Supriya Lifescience Ltd.
AGMSept. 29, 2023, 3 p.m.
Sr noTypeResolutionIiAS View
1OrdinaryAdoption of financial statements for the year ended 31 March 2023
2OrdinaryTo declare final dividend of Rs. 0.6 per share on face value Re. 2.0
3OrdinaryReappoint Ms. Shivani Satish Wagh (DIN: 08491420) as Director, liable to retire by rotation
4OrdinaryRatify remuneration of Rs. 200,000 to Rampurawala Mohammed A & Co as cost auditors for FY24


Enter your details


Summary

Particulars
Meeting Report
+ GST @ 18%
Amount
₹ 8,474
₹ 1,526

Total
₹ 10,000